Network


Latest external collaboration on country level. Dive into details by clicking on the dots.

Hotspot


Dive into the research topics where Yoshifuku Nakayama is active.

Publication


Featured researches published by Yoshifuku Nakayama.


Pathology International | 1997

Gastric carcinosarcoma (sarcomatoid carcinoma) with rhabdomyoblastic and osteoblastic differentiation

Yoshifuku Nakayama; Hiroshi Murayama; Hiroshi Iwasaki; Shinichi Iwanaga; Masahiro Kikuchi; Seiyo Ikeda; Mitsuo Okada; Yoshihiko Iizuka; Akinori Iwashita

A rare case of carclnosarcoma (sarcomatoid carcinoma) with rhabdomyoblastic and osteoblastic differentlatlon occurrlng in the gastric remnant is reported. A 69‐year‐old Japanese man who had undergone a partial gastrectomy for a duodenal ulcer 30 years earlier, presented with anemla, eplgastralgia, and an abdominal mass. The diagnosls of gastric carcinosarcoma was made based on the findings of endoscoplc biopsies. The patient was thus scheduled to undergo a surgical operatlon, but he died of respiratory failure. At autopsy, a huge polypoid tumor measurlng 2Ox18times8 cm was located on the greater curvature of the gastric remnant. Microscopically, the tumor conslsted of Intimately mixed tubular adenocarcinoma and heterologous mesenchymal elements contalning rhabdomyosarcoma and osteosarcoma. Between these components, a morphological transition from the adenocarclnoma element to the sarcomatous element was observed. Ultrastructually, rhabdomyoblastlc dlfferentlation was conflrmed In the sarcomatous areas. lmmunocytochemlcal expresslons of epithelial markers includlng epithelial membrane antlgen and cytokeratlns (35bHll and 34bE12) were recognlzed not only in the carclnomatous cells but also In the sarcomatous cells. These findlngs suggest that carclnomatous cells appear to transform Into cells wlth sarcomatous features.


The American Journal of Surgical Pathology | 2005

Intraductal tubular adenoma of the pancreas, pyloric gland type: a clinicopathologic and immunohistochemical study of 6 cases.

Yoshifuku Nakayama; Hiroshi Inoue; Yoshihiro Hamada; Morishige Takeshita; Hiroshi Iwasaki; Kensei Maeshiro; Shinichi Iwanaga; Hiroki Tani; Shinichirou Ryu; Yohichi Yasunami; Seiyo Ikeda

Abstract:The intraductal tubular adenoma (ITA), pyloric gland type, of the pancreas is an uncommon benign tumor, akin to the pyloric gland type adenoma of the gallbladder. We report 6 cases of ITA of the pancreas: 3 male and 3 female aged 50 to 79 years (mean, 63.5 years; median, 65 years); all were examined clinicopathologically. Four patients showed no symptoms, but appetite loss and/or general fatigue presented in two. Grossly, all tumors formed a localized polypoid mass protruding into the lumen of the dilated pancreatic duct. Five of the six tumors were found within the main duct, and the other arose within the branch duct of the pancreas. Microscopically, the tumors were composed of closely packed tubular glands resembling pyloric type glands. They were lined by columnar or cuboidal epithelial cells with foci of mild to moderate dysplastic change. In 2 cases, the adjacent pancreas showed foci of intraductal papillary-mucinous adenoma. Histochemically, the tumors largely showed neutral mucin with a lesser amount of acidic mucin made up mainly of sialomucin. Endocrine cells were found in five tumors. Immunohistochemically, all tumors were labeled with M-GGMC-1 and MUC6, whereas MUC1 and MUC2 stains were negative. Pepsinogen II was positive in 5 tumors; thus, the results displayed a pattern of differentiation similar to those of ordinary gastric pyloric or metaplastic pyloric glands. DPC4 expression was maintained in all tumors and p53-positive nuclei were hardly encountered. All patients are alive with no evidence of disease 3 to 10.5 years after surgical resection.


Histopathology | 2011

Pathological and immunohistological findings and genetic aberrations of intestinal enteropathy-associated T cell lymphoma in Japan

Morishige Takeshita; Shotaro Nakamura; Kanta Kikuma; Yoshifuku Nakayama; Satoshi Nimura; Takashi Yao; Shogo Urabe; Satoshi Ogawara; Hirotoshi Yonemasu; Yoshifumi Matsushita; Kennosuke Karube; Akinori Iwashita

Takeshita M, Nakamura S, Kikuma K, Nakayama Y, Nimura S, Yao T, Urabe S, Ogawara S, Yonemasu H, Matsushita Y, Karube K & Iwashita A
(2011) Histopathology58, 395–407
Pathological and immunohistological findings and genetic aberrations of intestinal enteropathy‐associated T cell lymphoma in Japan


American Journal of Pathology | 2001

Expression of lysosome-associated membrane proteins in human colorectal neoplasms and inflammatory diseases.

Koh Furuta; Masato Ikeda; Yoshifuku Nakayama; Kenjiro Nakamura; Masao Tanaka; Naotaka Hamasaki; Masaru Himeno; Stanley R. Hamilton; J. Thomas August

The lysosome-associated membrane proteins (LAMPs)-1 and -2 are major constituents of the lysosomal membrane. These molecules are known to be among the most glycosylated proteins of several types of cells and cancer cells, and their expression in cancer cells is marked by a distinct difference in the structures of the oligosaccharides as compared to nonmalignant cells. We analyzed by immunohistochemistry the intensity and distribution of LAMP-1 and LAMP-2 in 9 human colorectal cancer cases and in 16 control cases, including inflammatory diseases (diverticulitis, ulcerative colitis, and Crohns disease). LAMP proteins were expressed more intensely in the epithelium of colorectal neoplasms than in normal mucosa (P < 0.05), and no significant differences were found between adenoma and cancer cells (P > 0.05) in the same tissue section. Further, in sites of inactive inflammatory diseases and nonneoplastic areas in cancer specimens, no significant increases in epithelial LAMP proteins were observed, even in the proliferative zone of the lower crypt epithelium. Northern blot analysis showed increased expression of LAMP-1 and LAMP-2A in two of three colorectal cancers examined and increased LAMP-2B in all three cancers. Our findings suggest that LAMPs are related to neoplastic progression, but there is no direct association between the expression of LAMP molecules and cell proliferation.


Histopathology | 2009

Clinicopathological characteristics of primary gastric T-cell lymphoma.

Kenichiro Kawamoto; Shotaro Nakamura; Akinori Iwashita; Jiro Watanabe; Yumi Oshiro; Yoshifuku Nakayama; Satoshi Nimura; Nobuhiro Kimura; Kunihiko Aoyagi; Takashi Yao; Shigeru Kuramochi; Atsuji Matsuyama; Kenji Kurihara; Koichi Ohshima; Morishige Takeshita

Aims:  To investigate the clinicopathological characteristics of 20 primary gastric T‐cell lymphoma (GTCL) cases without human T‐lymphotropic virus type I infection in Japan, a non‐endemic area for coeliac disease.


Surgery Today | 2001

An Immunohistochemical Examination of Basaloid Squamous Cell Carcinoma of the Esophagus: Report of a Case

Katsunobu Kawahara; Kouji Makimoto; Takafumi Maekawa; Satoshi Yamamoto; Takeshi Shiraishi; Satoshi Takahashi; Takayuki Shirakusa; Yoshifuku Nakayama; Masahiro Kikuchi

Abstract We recently encountered a patient with basaloid carcinoma of the esophagus with extensive node involvement. The patient died of hematogenous metastasis 6 months after surgery. The tumor expressed cytokeratin but did not express either Type IV collagen or laminin. Both tumor cells and metastatic lesions in the regional lymph nodes expressed p53, Bcl-2, and Ki-67 proteins, but did not express cyclin D1 proteins.


Pancreas | 2009

Diagnosis of small pancreatic cancer by endoscopic balloon-catheter spot pancreatography: an analysis of 29 patients.

Seiyo Ikeda; Kensei Maeshiro; Shinichiro Ryu; Kenji Ogata; Yohichi Yasunami; Yoshifuku Nakayama; Yoshihiro Hamada

Objectives: The diagnosis of small pancreatic cancer remains difficult. The present study describes the diagnostic value of endoscopic balloon-catheter spot pancreatography for small pancreatic cancer. Methods: Since April 1984, balloon spot pancreatography has been used to detect small-sized pancreatic cancer in patients having possible symptoms or findings of obstructive pancreatitis. Results: A resection was performed on 175 of 416 patients with conditions diagnosed as pancreatic cancer. Of the 175 patients, 23 (13%) had invasive carcinoma 2 cm or smaller based on histological measurements, 3 intraductal papillotubular adenocarcinoma, and 3 carcinoma in situ (CIS). Regarding invasive carcinoma, balloon pancreatography displayed duct abnormalities diagnosed as carcinoma in 20 of 22 patients, whereas carcinoma was suggested in 2. A definite diagnosis was obtained based on the findings of main duct stenosis or obstruction with marked stricture of the branch ducts (n = 18) and a filling defect in the main duct (n = 2). Moreover, this pancreatogram demonstrated an intraductal filling defect in 2 of 3 with intraductal carcinoma and dead twiglike findings in the branch ducts in 1 of 3 with CIS. Conclusions: Balloon spot pancreatography is an essential tool for the diagnosis of small ductal pancreatic cancer, and it also makes it possible to locate CIS lesions of the branch ducts.


Pathology International | 1997

Spindle cell carcinoma of the breast: A case report and an immunohistochemical study including p53 and Ki‐67 expression

Yoshifuku Nakayama; Hiroshi Iwasaki; Shinichi Iwanaga; Hiroshi Nakamura; Toyoo Shiroshita; Masahiro Kikuchi; Hiroshi Jozaki; Mikitoshi Hashimoto; Seiyo Ikeda

A rare case of spindle cell carcinoma (SpCC) of the breast occurring In a 51‐yearold Japanese woman Is reported. A firm and well‐circumscribed tumor, measuring 9times8.5times8.5 cm, was located on the upper lateral region of the right breast. Microscopically, the tumor consisted of sheets of both malignant spindle cells and poorly differentiated ductal carcinoma containing squamold islands with gradual transition to the spindle cell component. The Immunocyto chemical expression of epithelial markers was recognized in the spindle cells, as well as in the carcinomatous cells. Moreover, the spindle cell component expressed vimentin, α‐smooth muscle actln and S‐100 protein. Ultrastructurally, in addition to the features of adenocarcinoma, squamous or rnyoeptthelial differentiation was confirmed in the spindle cell component. These findings thus suggest an epithelial origin with squamous differentiations and myoepithellal participation In the genesis of SpCC. In a comparative study, the expression of p53 protein and KI‐67 as a proliferation marker In each component of this tumor was also Investigated. The mean p53 labeling index (LI) in both the carcinomatous and spindle cell area was similar, however the mean MIB‐1 LI in the spindle cell area was significantly higher than that in the carcinomatous area. The results indicate that p53 over‐expression is Involved In the tumorigenesis of both components in the SpCC, and the spindle cell component shows a higher degree of proliferative activity than the carcinomatous component.


Journal of Gastroenterology | 1996

Effect of the eradication ofHelicobacter pylori on duodenal ulcer healing and ulcer relapse: Randomized controlled study in Japan

Takuro Shirotani; Mitsuo Okada; Hiroshi Murayama; Kazuhiro Maeda; Mitsuru Seo; Nobuo Okabe; Tsukane Nakahara; Kohji Oh; Yoshifuku Nakayama; Kiyomi Hoshiko; Kazuto Oda; Makoto Okumura

To investigate the effect of the eradication ofHelicobacter pylori on the healing and relapse of duodenal ulcers. 50 patients with active duodenal ulcer andH. pylori infection were randomly allocated to two treatment groups. One group (cimetidine group) received cimetidine 400mg twice daily for 6 weeks and the other group (double-therapy group) received 300mg amoxicillin granules and 250 mg metronidazole thrice daily for 2 weeks, in addition to the same regimen of cimetidine as the cimetidine group. Forty-two patients completed the study. After confirmation of ulcer scar, all patients were followed up for 6 months while receiving treatment with teprenone, an agent that does not affect acid secretion or the eradication ofH. pylori. The healing rates at 6 weeks were 90% in the cimetidine group and 95.5% in the double-therapy group.H. pylori eradication occurred in 0% of the cimetidine group and in 73.7% of the double-therapy group (P-0.004). The cumulative relapse rates in the two groups at 6 months were 64.3% and 11.1%, respectively (P=0.0007). In the double-therapy group, the cumulative relapse rate at 6 months in the patients in whomH. pylori persisted was 50% (2/4); the rate was 0% (0/14) in the patients in whomH. pylori had been eradicated (P=0.005). Histological gastritis significantly improved compared with the baseline in the double-therapy group, but no such improvement was seen in the cimetidine group. White scarring was found in 7.1% of the cimetidine group and in 83.3% of the double-therapy group after 6 months (P=0.0001). The eradication ofH. pylori markedly decreased the relapse rate in duodenal ulcer patients, and it significantly improved both the grade of gastritis and the quality of the ulcer scar.


American Journal of Clinical Pathology | 2009

FU-MK-1 expression in human gallbladder carcinoma: an antigenic prediction marker for a better postsurgical prognosis.

Takeaki Ikeda; Yoshifuku Nakayama; Yoshihiro Hamada; Morishige Takeshita; Hiroshi Iwasaki; Kensei Maeshiro; Yuichi Yamashita; Masahide Kuroki; Seiyo Ikeda

Gallbladder carcinoma is an aggressive type of neoplasm difficult to cure by conventional procedures. Because of the lack of reliable markers for assessing the prognosis, this retrospective study was designed to investigate the prognostic significance of MK-1 overexpression in human carcinoma of the gallbladder. Immunohistochemical staining using monoclonal antibody FU-MK-1 (MK-1 antigen) was performed on paraffin-embedded tissues from 63 patients who had undergone surgical resection for gallbladder carcinoma. Expression of MK-1 was found in 50 (79%) of 63 tumor samples. All 21 papillary and 12 of 13 well-differentiated tubular adenocarcinomas but only 1 of 8 poorly differentiated adenocarcinomas were positive for FU-MK-1. Multivariate analysis showed that only MK-1 expression was an independent prognostic marker (P = .0473), and Kaplan-Meier curves showed that MK-1 expression was significantly related to increased overall survival (P < .0001). These results suggest that MK-1 expression is a prognostic marker in gallbladder carcinoma.

Collaboration


Dive into the Yoshifuku Nakayama's collaboration.

Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Researchain Logo
Decentralizing Knowledge